These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 29921509)

  • 1. Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approach.
    Chan CYS; Roberts O; Rajoli RKR; Liptrott NJ; Siccardi M; Almond L; Owen A
    Drug Metab Pharmacokinet; 2018 Aug; 33(4):179-187. PubMed ID: 29921509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anthocyanidins and anthocyanins on the expression and catalytic activities of CYP2A6, CYP2B6, CYP2C9, and CYP3A4 in primary human hepatocytes and human liver microsomes.
    Srovnalova A; Svecarova M; Zapletalova MK; Anzenbacher P; Bachleda P; Anzenbacherova E; Dvorak Z
    J Agric Food Chem; 2014 Jan; 62(3):789-97. PubMed ID: 24387788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying Stable Isotope Labeled Amino Acids in Micropatterned Hepatocyte Coculture to Directly Determine the Degradation Rate Constant for CYP3A4.
    Takahashi RH; Shahidi-Latham SK; Wong S; Chang JH
    Drug Metab Dispos; 2017 Jun; 45(6):581-585. PubMed ID: 28289057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac.
    Ramsden D; Zhou J; Tweedie DJ
    Drug Metab Dispos; 2015 Sep; 43(9):1307-15. PubMed ID: 26076693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Suppression of CYP3A4 mRNA and Enzyme Activity by Epidermal Growth Factor in Plated Human Hepatocytes.
    Zhang JG; Wang D; Ho T; Clark RJ; Stresser DM
    Drug Metab Lett; 2017; 11(2):119-127. PubMed ID: 29189189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of In Silico Prediction Models for CYP3A4 and CYP2B6 Induction in Human Hepatocytes by Multiple Regression Analysis Using Azole Compounds.
    Nagai M; Konno Y; Satsukawa M; Yamashita S; Yoshinari K
    Drug Metab Dispos; 2016 Aug; 44(8):1390-8. PubMed ID: 27208383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD28 monoclonal antibody-stimulated cytokines released from blood suppress CYP1A2, CYP2B6, and CYP3A4 in human hepatocytes in vitro.
    Czerwiński M; Kazmi F; Parkinson A; Buckley DB
    Drug Metab Dispos; 2015 Jan; 43(1):42-52. PubMed ID: 25326287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes.
    Price RJ; Scott MP; Giddings AM; Walters DG; Stierum RH; Meredith C; Lake BG
    Xenobiotica; 2008 Jun; 38(6):574-86. PubMed ID: 18570159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
    Kumar S; Bouic PJ; Rosenkranz B
    J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of endosulfan and methoxychlor involving CYP3A4 and CYP2B6 in human HepaRG cells.
    Savary CC; Jossé R; Bruyère A; Guillet F; Robin MA; Guillouzo A
    Drug Metab Dispos; 2014 Aug; 42(8):1235-40. PubMed ID: 24832206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.
    Aitken AE; Lee CM; Morgan ET
    Free Radic Biol Med; 2008 Mar; 44(6):1161-8. PubMed ID: 18206661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
    Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions.
    Zhang G; Ou R; Li F; Wu J; Zheng L; Tong Y; Liu Y; Liu Z; Lu L
    J Ethnopharmacol; 2016 Mar; 180():104-13. PubMed ID: 26805467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 309 molecules as inducers of CYP3A4, CYP2B6, CYP1A2, OATP1B1, OCT1, MDR1, MRP2, MRP3 and BCRP in cryopreserved human hepatocytes in sandwich culture.
    Badolo L; Jensen B; Säll C; Norinder U; Kallunki P; Montanari D
    Xenobiotica; 2015 Feb; 45(2):177-87. PubMed ID: 25183402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6.
    Chen X; Pan LQ; Naranmandura H; Zeng S; Chen SQ
    PLoS One; 2012; 7(6):e38495. PubMed ID: 22719896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells.
    Le Vée M; Bruyère A; Jouan E; Fardel O
    Int Immunopharmacol; 2020 Jun; 83():106439. PubMed ID: 32234672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Human Liver Cell Model and Cytochrome P450 Substrate-Inhibitor Panel for Studies of Dasatinib and Warfarin Interactions.
    Zakharyants AA; Burmistrova OA; Poloznikov AA
    Bull Exp Biol Med; 2017 Feb; 162(4):515-519. PubMed ID: 28243904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine Nitration Contributes to Nitric Oxide-Stimulated Degradation of CYP2B6.
    Lee CM; Wilderman PR; Park JW; Murphy TJ; Morgan ET
    Mol Pharmacol; 2020 Sep; 98(3):267-279. PubMed ID: 32817462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system.
    Lee CM; Tripathi S; Morgan ET
    Free Radic Biol Med; 2017 Jul; 108():478-486. PubMed ID: 28427998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.